Relapse and Treatment Adherence in Patients with Schizophrenia Switching from Paliperidone Palmitate Once-Monthly to Three-Monthly Formulation: A Retrospective Health Claims Database Analysis

Relapse and Treatment Adherence in Patients with Schizophrenia Switching from Paliperidone Palmitate Once-Monthly to Three-Monthly Formulation: A Retrospective Health Claims Database Analysis

Gang Li,1 Alexander Keenan,2 Mehmet Daskiran,1 Maju Mathews,3 Isaac Nuamah,3 Camille Orman,3 Kruti Joshi,4 Arun Singh,3 Annabelle Godet,5 Katalin Pungor,6 Srihari Gopal3 1Janssen Research & Development, LLC, Raritan, NJ, USA; 2Janssen Research & Development, LLC, Pennington, NJ, USA; 3Jansse...

Full description

Bibliographic Details
Main Authors: Li G, Keenan A, Daskiran M, Mathews M, Nuamah I, Orman C, Joshi K, Singh A, Godet A, Pungor K, Gopal S
Format: Article
Language:English
Published: Dove Medical Press 2021-10-01
Series:Patient Preference and Adherence
Subjects:
health claims
paliperidone palmitate
relapse rate
schizophrenia
three-monthly
treatment adherence
Online Access:https://www.dovepress.com/relapse-and-treatment-adherence-in-patients-with-schizophrenia-switchi-peer-reviewed-fulltext-article-PPA

Internet

https://www.dovepress.com/relapse-and-treatment-adherence-in-patients-with-schizophrenia-switchi-peer-reviewed-fulltext-article-PPA

Similar Items